Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab

Cetuximab, an antibody against the Epidermal Growth Factor Receptor (EGFR) has shown efficacy in treating head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer and non-small cell lung cancer (NSCLC). Despite the clinical success of cetuximab, many patients do not respond to cet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Iida, Mari, Bahrar, Harsh, Brand, Toni M, Pearson, Hannah E, Coan, John P, Orbuch, Rachel A, Flanigan, Bailey G, Swick, Adam D, Prabakaran, Prashanth, Lantto, Johan, Horak, Ivan D., Kragh, Michael, Salgia, Ravi, Kimple, Randy J, Wheeler, Deric L
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010956/
https://ncbi.nlm.nih.gov/pubmed/27422810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-16-0012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados